We are very pleased to announce that Celcuity has submitted its supplemental NDA to the FDA for REVTORPYK™ (gedatolisib. You can find more details in the press release: https://t.co/2CMkh3Gmbs
$CELC
$BMYRT Here’s key portion of the U.S. Court of Appeals’ Order reversing in our favor.
We’ll see what comes next, but make no mistake: this is a huge loss for Bristol. At this point, there’s little substantive reason to keep delaying mediation
Time to pay the piper, Bristol. 💰
REVTORPYK™ (gedatolisib) in combination with fulvestrant, w/or/wo palbociclib, is recommended by the NCCN Clinical Practice Guidelines in Oncology as a preferred Category 1 second-line and/or subsequent-line therapy. Details in our press release: https://t.co/cIjr1i0Wq1 $CELC
#NEWS: The FDA has approved our targeted therapy for patients with HR+/HER2-, PIK3CA wild-type locally advanced or metastatic breast cancer following progression on prior therapy. Learn more: https://t.co/5CRq2e4wiO
#FDAApproval#BreastCancer
$CELC
$CELC 1.9 month gap between doublet and triplet may sound small…until you consider that US, Canada, Western Europe, and Asia Pacific which makes up roughly 60% of the entire trial population the data showed hugely in favor of the triplet:
16.6 months median pfs & hr of 0.14
>be Tang Tan
>24 YEARS at Apple
>VP of Product Design, iPhone AND Apple Watch
>you know every team. every project.
>every name worth taking
>months BEFORE you leave:
>meet with OpenAI’s people
>email yourself Apple supplier intel
>apple is literally paying you while you betray them
2024: leave, co-found io with Jony Ive
2025: OpenAI buys it for $6.5 BILLION
>a one-year-old company. no product
>you’re now Chief Hardware Officer
>you’re paid in OpenAI pre-IPO shares
begin the great unbuilding of Apple
>one by one, apple’s hardware people vanish
>engineers. designers. supply chain leads
>you know which head holds which secret
>you are the mastermind
>you pick accordingly
>interviews are not interviews
>drop secret codenames like you still work there:
> “what’s the plan?”
>candidates cram STOLEN FILES the night before like it’s finals week
>“bring Actual parts for show and tell”
>apple employees smuggling batteries and logic boards out of Apple Park in their bags
>one guy, genuinely confused: “didn’t even know we could take those from the office”
>you knew
>hand every new hire Apple’s own security manual BEFORE they resign
>the document literally lists the rules they’re about to break
>openai staff, cheerfully: “a checklist that Tang put together”
>tang did not put it together
>APPLE put it together
>tang took it on his way out
Tang Tan spent 24 years learning how Apple keeps secrets. Then 14 months teaching people how to leave with them.
APPLE IS PERSONALLY SUING HIM FOR: TRADE SECRET THEFT. BREACH OF CONTRACT. WILLFUL. EXEMPLARY DAMAGES.
$CELC 1.9 month gap between doublet and triplet may sound small…until you consider that US, Canada, Western Europe, and Asia Pacific which makes up roughly 60% of the entire trial population the data showed hugely in favor of the triplet:
16.6 months median pfs & hr of 0.14